Bellevue Life Sciences Acquisition Corp. financial data

Symbol
BLAC, BLACR, BLACU, BLACW on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
10900 Ne 4 Th Street, Suite 2300, Bellevue, WA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.45 % -88.3%
Debt-to-equity -108 % +27.1%
Return On Equity 10.1 %
Return On Assets -1.65 % -287%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.04M shares -55.4%
Common Stock, Shares, Outstanding 2.16M shares 0%
Entity Public Float 70.8T USD
Common Stock, Value, Issued 216 USD 0%
Weighted Average Number of Shares Outstanding, Basic 4.04M shares -55.4%
Weighted Average Number of Shares Outstanding, Diluted 4.04M shares -55.4%

Income Statement

Label TTM Value / Value Unit Change %
Income Tax Expense (Benefit) 377K USD -64.6%
Net Income (Loss) Attributable to Parent -475K USD -200%
Earnings Per Share, Basic -0.1 USD/shares -700%
Earnings Per Share, Diluted -0.1 USD/shares -700%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 12.2K USD -78.9%
Assets, Current 39.6K USD -51.9%
Assets 20.9M USD -71%
Liabilities, Current 3.94M USD +257%
Liabilities 6.01M USD +89.3%
Retained Earnings (Accumulated Deficit) -5.75M USD -134%
Stockholders' Equity Attributable to Parent -5.75M USD -134%
Liabilities and Equity 20.9M USD -71%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -41.8K USD +13.7%
Net Cash Provided by (Used in) Financing Activities 150K USD
Net Cash Provided by (Used in) Investing Activities -120K USD +99.8%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 2.16M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12.2K USD -78.9%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 0 USD
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%